Assignee
NUEVOLUTION AS
DK·24 granted patents·12 pending applications·226 citations·filing 2002–2023
Top patents by PatentIndex Score
36 records- 0196US7704925B2Ligational encoding using building block oligonucleotidesNUEVOLUTION AS·Filed 2005·Granted Apr 27, 2010·49 cites·27 claims
- 0295US10287576B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2016·Granted May 14, 2019·19 cites·22 claims
- 0394US9885035B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2016·Granted Feb 6, 2018·6 cites·52 claims
- 0493US7727713B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2002·Granted Jun 1, 2010·39 cites·241 claims
- 0592US10077440B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2015·Granted Sep 18, 2018·5 cites·52 claims
- 0692US9284600B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2013·Granted Mar 15, 2016·9 cites·18 claims
- 0792US7413854B2Method for synthesising templated moleculesNUEVOLUTION AS·Filed 2003·Granted Aug 19, 2008·39 cites·145 claims
- 0891US9487775B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2015·Granted Nov 8, 2016·6 cites·71 claims
- 0988US10689383B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2015·Granted Jun 23, 2020·6 cites·59 claims
- 1085US10669538B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2016·Granted Jun 2, 2020·2 cites·106 claims
- 1184US10683293B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2015·Granted Jun 16, 2020·3 cites·42 claims
- 1284US7915201B2Ligational encoding of small moleculesNUEVOLUTION AS·Filed 2004·Granted Mar 29, 2011·40 cites·31 claims
- 1381US11254681B2Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseasesNUEVOLUTION AS·Filed 2020·Granted Feb 22, 2022·1 cites·54 claims
- 1475US12441704B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2023·Granted Oct 14, 2025·0 cites·18 claims
- 1572US11001835B2Method for the synthesis of a bifunctional complexNUEVOLUTION AS·Filed 2018·Granted May 11, 2021·0 cites·32 claims
- 1669US11702652B2Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2020·Granted Jul 18, 2023·0 cites·21 claims
- 1768US10731151B2Method for synthesising templated moleculesNUEVOLUTION AS·Filed 2014·Granted Aug 4, 2020·0 cites·47 claims
- 1867US11965209B2Method for obtaining structural information concerning an encoded molecule and method for selecting compoundsNUEVOLUTION AS·Filed 2021·Granted Apr 23, 2024·0 cites·20 claims
- 1967US10752640B2Compounds active towards bromodomainsNUEVOLUTION AS·Filed 2015·Granted Aug 25, 2020·2 cites·38 claims
- 2067US2022340893A1Bi-functional complexes and methods for making and using such complexesNUEVOLUTION AS·Filed 2021·Application pending·0 cites
- 2167US2019330618A1Enzymatic encoding methods for efficient synthesis of large librariesNUEVOLUTION AS·Filed 2019·Application pending·0 cites
- 2266US11685727B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2020·Granted Jun 27, 2023·0 cites·16 claims
- 2365US9688980B2Templated molecules and methods for using such moleculesNUEVOLUTION AS·Filed 2014·Granted Jun 27, 2017·0 cites·14 claims
- 2462US2007026397A1Method for producing second-generation libraryNUEVOLUTION AS·Filed 2004·Application pending·0 cites
- 2561US2025382308A1Compounds active towards bromodomainsNUEVOLUTION AS·Filed 2023·Application pending·0 cites
- 2654US11780843B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2021·Granted Oct 10, 2023·0 cites·20 claims
- 2754US11613532B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2021·Granted Mar 28, 2023·0 cites·21 claims
- 2852US11447479B2Compounds active towards nuclear receptorsNUEVOLUTION AS·Filed 2020·Granted Sep 20, 2022·0 cites·21 claims
- 2952US2011230419A1Iap binding compoundsNUEVOLUTION AS·Filed 2009·Application pending·0 cites
- 3048US2006234231A1Microarrays displaying encoded moleculesNUEVOLUTION AS·Filed 2003·Application pending·0 cites
- 3148US2006269920A1Method for obtaining structural information about an encoded moleculeNUEVOLUTION AS·Filed 2004·Application pending·0 cites
- 3248US2005247001A1Building block forming a c-c or a c-hetero atom bond uponreactionNUEVOLUTION AS·Filed 2003·Application pending·0 cites
- 3346US2006099589A1Gene shuffling by template switchingNUEVOLUTION AS·Filed 2003·Application pending·0 cites
- 3443US2003143561A1Nucleoside derivatives for library preparationNUEVOLUTION AS·Filed 2002·Application pending·0 cites
- 3540US2007213519A1Building Block Forming A C=C Double Bond Upon ReactionNUEVOLUTION AS·Filed 2003·Application pending·0 cites
- 3638US2009239211A1Method For Enrichment Involving Elimination By Mismatch HybridisationNUEVOLUTION AS·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NUEVOLUTION AS files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →